© Copyright 2025 American Medical Association. All rights reserved.
| Short Descr | ONC PNCRTC CA MULT IA ECLIA | Medium Descr | ONC PNCRTC CA MULT IA ECLIA SRM ALG | Long Descr | Oncology (pancreatic cancer), multiplex immunoassay of C5, C4, cystatin C, factor B, osteoprotegerin (OPG), gelsolin, IGFBP3, CA125 and multiplex electrochemiluminescent immunoassay (ECLIA) for CA19-9, serum, diagnostic algorithm reported qualitatively as positive, negative, or borderline | CLIA Waived (QW) | No | APC Status Indicator | Non-Covered Service, not paid under OPPS | Berenson-Eggers TOS (BETOS) | none | MUE | 1 |
|
Date
|
Action
|
Notes
|
|---|---|---|
| 2023-01-01 | Added | First appearance in codebook. |
| 2022-10-01 | Added | Code added. |
Get instant expert-level medical coding assistance.